Xiamen Ade Biological Technology Co., Ltd. (hereinafter referred to as "the Company" or "Ade Biological") held the 11th meeting of the 4th Board of Directors on April 14, 2026, where it reviewed and approved the proposal on the repurchase and cancellation of certain restricted stocks under the 2023 Restricted Stock Incentive Plan. The Board and all members guarantee that the content of the information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
Important Content Reminder:
- Number of restricted stocks to be repurchased: 1,430,975 shares;
- Repurchase price for the initially granted restricted stocks: 11.32 yuan/share plus the sum of bank interest for the same period.